New Delhi: Zee News reporter Pooja Makkar became the first Indian journalist to get Covaxin, the indigenous vaccine developed by Bharat Biotech against the novel coronavirus. Makkar said that she decided to get Covaxin as “it was necessary to instill confidence among common people that the vaccine is fully safe.”Also Read - Is Genome Sequencing Ultimate Solution to Detect Omicron Variant? Here’s What Experts Have to Say

A controversy has erupted after the Drugs Controller General of India (DCGI) approved Covaxin for emergency use without Phase III trial data. Several experts and Opposition leaders have claimed ‘premature’ clearance could risk lives and fuel vaccine hesitancy in India. Also Read - Omicron Scare: Serum Institute Seeks DCGI's Approval for Covishield as Booster Dose

Meanwhile, sharing her experience, the reporter said that she has not suffered any complication so far.  After undergoing requisite tests, Makkar was inocculated yesterday at 2 PM at AIIMS, Delhi. She will get another shot of Covaxin after 4 weeks (28 days). Also Read - Not Just Airports, Indian Railways Too Tightens Guidelines For Passengers Amid Omicron Threat | Details Here